BioSpace News Archive

Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, announced the formation of its new Scientific Advisory Board.

The risk of having a future stroke caused by a severe blockage in an artery in the neck that is not currently causing any symptoms is so low that most patients with this condition — asymptomatic carotid stenosis — could potentially be treated with the newest medications and may not require surgery, new Kaiser Permanente research suggests.

Olympus, a global leader in designing and delivering innovative medical technology solutions, announced its support for the Centers for Medicare & Medicaid Services decision to expand lung cancer screening eligibility for those covered by Medicare.

Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that the company’s automated polyp detection algorithm for colorectal cancer (CRC) screening, SKOUT, demonstrated statistical superiority of overall adenoma detection in a randomized, controlled prospective clinical trial, compared to routine colonoscopy.

Invenio Imaging, the leader in intraoperative fresh tissue imaging, announced today the CE Mark for the NIO Glioma Reveal image analysis module. NIO Glioma Reveal is based on deep learning and allows neurosurgeons to identify areas of cancer infiltration in patients undergoing primary treatment of a diffuse glioma.

Increasing incidence of chronic and acute diseases across the globe, rising geriatric population, and high usage of smart wearable medical devices are some key factors expected to drive global market growth

Increasing prevalence of skin disorders and infections such as acne, eczema, psoriasis, rapid advancements in topical drug formulations, high prevalence of diabetes, and rising disposable income are some key factors expected to drive global Topical Drug Delivery market revenue growth.

According to Emergen Research, the global spinal surgery devices market size was USD 10.22 billion in 2019 and is expected to reach USD 14.70 billion in 2027 and register a revenue CAGR of 4.6% during the forecast period, 2020-2027.

Increasing incidence of target diseases such as diabetes, arthritis across the globe coupled with high incidence of bone injuries is expected to stimulate market growth

Rise in awareness of gastrointestinal disorders, muscle improvement and fat reduction supplements are the major factors influencing market growth.